• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNAs 定义并维持的胶质母细胞瘤发育分类学。

A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs.

机构信息

Center for Biomedical Informatics, Harvard Medical School, Boston, MA, USA.

出版信息

Cancer Res. 2011 May 1;71(9):3387-99. doi: 10.1158/0008-5472.CAN-10-4117. Epub 2011 Mar 8.

DOI:10.1158/0008-5472.CAN-10-4117
PMID:21385897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3085663/
Abstract

mRNA expression profiling has suggested the existence of multiple glioblastoma subclasses, but their number and characteristics vary among studies and the etiology underlying their development is unclear. In this study, we analyzed 261 microRNA expression profiles from The Cancer Genome Atlas (TCGA), identifying five clinically and genetically distinct subclasses of glioblastoma that each related to a different neural precursor cell type. These microRNA-based glioblastoma subclasses displayed microRNA and mRNA expression signatures resembling those of radial glia, oligoneuronal precursors, neuronal precursors, neuroepithelial/neural crest precursors, or astrocyte precursors. Each subclass was determined to be genetically distinct, based on the significant differences they displayed in terms of patient race, age, treatment response, and survival. We also identified several microRNAs as potent regulators of subclass-specific gene expression networks in glioblastoma. Foremost among these is miR-9, which suppresses mesenchymal differentiation in glioblastoma by downregulating expression of JAK kinases and inhibiting activation of STAT3. Our findings suggest that microRNAs are important determinants of glioblastoma subclasses through their ability to regulate developmental growth and differentiation programs in several transformed neural precursor cell types. Taken together, our results define developmental microRNA expression signatures that both characterize and contribute to the phenotypic diversity of glioblastoma subclasses, thereby providing an expanded framework for understanding the pathogenesis of glioblastoma in a human neurodevelopmental context.

摘要

mRNA 表达谱分析表明胶质母细胞瘤存在多个亚型,但它们的数量和特征在不同的研究中有所不同,其发展的病因尚不清楚。在这项研究中,我们分析了来自癌症基因组图谱 (TCGA) 的 261 个 microRNA 表达谱,确定了胶质母细胞瘤的五个具有临床和遗传特征的亚型,每个亚型都与不同的神经前体细胞类型有关。这些基于 microRNA 的胶质母细胞瘤亚型显示出 microRNA 和 mRNA 表达特征,类似于放射状胶质细胞、少突前体细胞、神经元前体细胞、神经上皮/神经嵴前体细胞或星形胶质细胞前体细胞。每个亚型在患者种族、年龄、治疗反应和生存方面都存在显著差异,因此被确定为具有遗传特征。我们还发现了几个 microRNAs 作为胶质母细胞瘤中特定于亚型的基因表达网络的有效调节剂。其中最重要的是 miR-9,它通过下调 JAK 激酶的表达和抑制 STAT3 的激活,抑制胶质母细胞瘤的间质分化。我们的研究结果表明,microRNAs 通过调节几种转化的神经前体细胞类型的发育生长和分化程序,成为胶质母细胞瘤亚型的重要决定因素。总之,我们的研究结果定义了发育 microRNA 表达特征,这些特征既表征又促进了胶质母细胞瘤亚型的表型多样性,从而为在人类神经发育背景下理解胶质母细胞瘤的发病机制提供了扩展的框架。

相似文献

1
A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs.miRNAs 定义并维持的胶质母细胞瘤发育分类学。
Cancer Res. 2011 May 1;71(9):3387-99. doi: 10.1158/0008-5472.CAN-10-4117. Epub 2011 Mar 8.
2
Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas.辐射诱导的细胞外囊泡 (EV) 释放 miR-603 促进胶质母细胞瘤中 IGF1 介导的干细胞状态。
EBioMedicine. 2020 May;55:102736. doi: 10.1016/j.ebiom.2020.102736. Epub 2020 Apr 28.
3
Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.根据 MGMT 启动子甲基化情况,对 IDH 野生型胶质母细胞瘤的分子差异进行研究。
Neuro Oncol. 2018 Feb 19;20(3):367-379. doi: 10.1093/neuonc/nox160.
4
A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.一种对O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化的胶质母细胞瘤患者具有预后和预测价值的五miRNA特征。
Oncotarget. 2015 Oct 6;6(30):29285-95. doi: 10.18632/oncotarget.4978.
5
A novel volume-age-KPS (VAK) glioblastoma classification identifies a prognostic cognate microRNA-gene signature.一种新型的体积年龄-KPS(VAK)胶质母细胞瘤分类方法确定了一种预后相关的 microRNA-基因特征。
PLoS One. 2012;7(8):e41522. doi: 10.1371/journal.pone.0041522. Epub 2012 Aug 3.
6
Transcriptional diversity of long-term glioblastoma survivors.长期胶质母细胞瘤幸存者的转录多样性。
Neuro Oncol. 2014 Sep;16(9):1186-95. doi: 10.1093/neuonc/nou043. Epub 2014 Mar 23.
7
Genetic secrets of long-term glioblastoma survivors.长期胶质母细胞瘤幸存者的遗传秘密。
Bosn J Basic Med Sci. 2019 May 20;19(2):116-124. doi: 10.17305/bjbms.2018.3717.
8
microRNA-181d associated with the methylation status of the MGMT gene in Glioblastoma multiforme cancer stem cells submitted to treatments with ionizing radiation and temozolomide.miRNA-181d 与胶质母细胞瘤多形性癌症干细胞中 MGMT 基因的甲基化状态相关,这些干细胞接受了电离辐射和替莫唑胺的治疗。
Brain Res. 2019 Oct 1;1720:146302. doi: 10.1016/j.brainres.2019.146302. Epub 2019 Jun 18.
9
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma.微小RNA阵列筛选揭示了胶质母细胞瘤中miR-181d-5p和miR-409-3p之间对O6-甲基鸟嘌呤-DNA甲基转移酶的协同调控作用。
Oncotarget. 2016 May 10;7(19):28195-206. doi: 10.18632/oncotarget.8618.
10
Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients.基于 microRNA 表达特征的风险评分是胶质母细胞瘤患者独立的预后分类器。
Carcinogenesis. 2014 Dec;35(12):2756-62. doi: 10.1093/carcin/bgu212. Epub 2014 Oct 16.

引用本文的文献

1
Mapping chromatin remodelling in glioblastoma identifies epigenetic regulation of key molecular pathways and novel druggable targets.胶质母细胞瘤中染色质重塑的图谱绘制确定了关键分子途径的表观遗传调控及新的可药物作用靶点。
BMC Biol. 2025 Feb 7;23(1):26. doi: 10.1186/s12915-025-02127-9.
2
Unravelling the mosaic: Epigenetic diversity in glioblastoma.解析镶嵌现象:胶质母细胞瘤中的表观遗传多样性
Mol Oncol. 2024 Dec;18(12):2871-2889. doi: 10.1002/1878-0261.13706. Epub 2024 Aug 15.
3
MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces.

本文引用的文献

1
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.鉴定出一种 CpG 岛甲基化表型,它定义了神经胶质瘤的一个独特亚群。
Cancer Cell. 2010 May 18;17(5):510-22. doi: 10.1016/j.ccr.2010.03.017. Epub 2010 Apr 15.
2
BMP-induced REST regulates the establishment and maintenance of astrocytic identity.BMP 诱导的 REST 调节星形胶质细胞特性的建立和维持。
J Cell Biol. 2010 Apr 5;189(1):159-70. doi: 10.1083/jcb.200908048. Epub 2010 Mar 29.
3
MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.
miR-223-3p 在癌症发生发展和癌症药物耐药中的作用:同一枚硬币,两面不同。
Int J Mol Sci. 2024 Jul 26;25(15):8191. doi: 10.3390/ijms25158191.
4
The potential of miRNA-based approaches in glioblastoma: An update in current advances and future perspectives.基于微小RNA的方法在胶质母细胞瘤中的潜力:当前进展与未来展望的最新情况
Curr Res Pharmacol Drug Discov. 2024 Jun 29;7:100193. doi: 10.1016/j.crphar.2024.100193. eCollection 2024.
5
The RAS oncogene in brain tumors and the involvement of let-7 microRNA.脑肿瘤中的 RAS 癌基因与 let-7 微 RNA 的关系。
Mol Biol Rep. 2024 Apr 18;51(1):531. doi: 10.1007/s11033-024-09439-z.
6
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas.成人脑胶质瘤的脑脊液液体活检评估。
Curr Oncol Rep. 2024 Apr;26(4):377-390. doi: 10.1007/s11912-024-01517-6. Epub 2024 Mar 15.
7
Use of microRNAs as Diagnostic, Prognostic, and Therapeutic Tools for Glioblastoma.微小RNA作为胶质母细胞瘤的诊断、预后和治疗工具的应用
Int J Mol Sci. 2024 Feb 20;25(5):2464. doi: 10.3390/ijms25052464.
8
Harnessing microRNA-enriched extracellular vesicles for liquid biopsy.利用富含微小RNA的细胞外囊泡进行液体活检。
Front Mol Biosci. 2024 Feb 21;11:1356780. doi: 10.3389/fmolb.2024.1356780. eCollection 2024.
9
Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges.循环 microRNAs 作为胰腺癌潜在的生物标志物:进展与挑战。
Int J Mol Sci. 2023 Aug 28;24(17):13340. doi: 10.3390/ijms241713340.
10
Artificial intelligence-driven pan-cancer analysis reveals miRNA signatures for cancer stage prediction.人工智能驱动的泛癌分析揭示了用于癌症分期预测的 miRNA 特征。
HGG Adv. 2023 Apr 3;4(3):100190. doi: 10.1016/j.xhgg.2023.100190. eCollection 2023 Jul 13.
microRNA-451 调节 LKB1/AMPK 信号通路并允许神经胶质瘤细胞适应代谢应激。
Mol Cell. 2010 Mar 12;37(5):620-32. doi: 10.1016/j.molcel.2010.02.018.
4
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.整合基因组分析确定了具有 PDGFRA、IDH1、EGFR 和 NF1 异常的胶质母细胞瘤的临床相关亚型。
Cancer Cell. 2010 Jan 19;17(1):98-110. doi: 10.1016/j.ccr.2009.12.020.
5
Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship.整合基因组分析揭示了一个调节胶质母细胞瘤存活的 microRNA/oncogene 簇。
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2183-8. doi: 10.1073/pnas.0909896107. Epub 2010 Jan 13.
6
GSMA: Gene Set Matrix Analysis, An Automated Method for Rapid Hypothesis Testing of Gene Expression Data.GSMA:基因集矩阵分析,一种用于基因表达数据快速假设检验的自动化方法。
Bioinform Biol Insights. 2009 Nov 24;1:49-62.
7
The transcriptional network for mesenchymal transformation of brain tumours.脑肿瘤间质转化的转录网络。
Nature. 2010 Jan 21;463(7279):318-25. doi: 10.1038/nature08712. Epub 2009 Dec 23.
8
Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes.成人神经干细胞区室中的基因突变组合决定了脑肿瘤表型。
EMBO J. 2010 Jan 6;29(1):222-35. doi: 10.1038/emboj.2009.327. Epub 2009 Nov 19.
9
Identification of microRNA activity by Targets' Reverse EXpression.通过靶基因的反向表达鉴定 microRNA 的活性。
Bioinformatics. 2010 Jan 1;26(1):91-7. doi: 10.1093/bioinformatics/btp598. Epub 2009 Nov 6.
10
microRNAs in gliomas: small regulators of a big problem.胶质瘤中的微小RNA:重大问题的微小调节因子
Neuromolecular Med. 2009;11(3):208-22. doi: 10.1007/s12017-009-8087-9.